January, 2024

article thumbnail

Advise Patients On Five Tips When Consuming Vitamins, Supplements, Energy Drinks

Pharmacy Times

By offering personalized guidance, promoting awareness, and fostering open communication, pharmacists can empower their patients to navigate the new year with a focus on both wellness and safety.

article thumbnail

Opinion: Defunding liberal arts is dangerous for health care

STAT

If you want an argument in favor of teaching the humanities, I suggest you ask a medical educator. Across the U.S., the age-old debate about the value of a liberal arts education has seemingly devolved into mortal combat, leaving the humanities in dire straits on college campuses. For example, the Atlantic recently reported on West Virginia University’s decision to gut its humanities programming, and the New York Times wondered whether the liberal arts will exist after the budget cuts hap

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

A category in chaos

Drug Store News

The future of phenylephrine, a widely used OTC decongestant, is up in the air.

116
116
article thumbnail

To Crush or Not to Crush: That is the Medication Administration Question

Pharmacy Times

Pharmacists are well suited to identify patients with dysphagia and educate patients and caregivers on when and how to safely crush and administer medication.

158
158
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Paxlovid Found Not to Reduce Long COVID Risk

Drug Topics

A new study found that 16.1% of patients treated with nirmatrelvir-ritonavir (Paxlovid) reported long COVID symptoms, compared to 14% of untreated patients.

603
603
article thumbnail

PharmaVoice’s Crystal Ball: What’s next in drug innovation and clinical trials

PharmaVoice

As advanced therapies and patient perspectives strengthen their foothold in R&D, pharma is poised to deliver impactful treatments in record time.

328
328

More Trending

article thumbnail

Some dementia patients might have reversible symptoms caused by cirrhosis, study says

STAT

The descent into dementia can feel like traversing a minefield, coming across new symptoms without the hope of a cure. But some dementia patients, even up to 10% of people diagnosed with the condition, might actually have undiagnosed liver disease and accompanying neurological problems, a new study in JAMA Open Network suggests. Most importantly, it’s possible their liver-related brain symptoms could be resolved with treatment.

145
145
article thumbnail

Merck is on the lookout for more opportunities within immunology

Pharmaceutical Technology

At the JP Morgan Healthcare conference, Merck (MSD) indicated its eagerness to continue to establish its place in the immunological space.

144
144
article thumbnail

Obstetrical Patient Dies After Inadvertent Administration of Digoxin for Spinal Anesthesia

Pharmacy Times

The ampule of digoxin was accidentally taken from automated dispensing cabinet instead of bupivacaine

181
181
article thumbnail

Florida Drug Importation Program Faces Nationwide Opposition From Pharmacy Organizations

Drug Topics

Just weeks after it gained FDA approval, pharmacy organizations have come forward to voice concerns about the safety and security of Florida’s drug importation program.

FDA 568
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Tonix closes in on the first new fibromyalgia drug in more than a decade

PharmaVoice

In addition to the chronic disease, the non-opioid drug may have applications in other painful conditions.

299
299
article thumbnail

Navigating A Unique Journey: Dr. Lindsey Moseley’s Inspiring Path in Pharmacy Education

Pharmacy Is Right For Me

A pharmacy education provides diverse opportunities, ranging from patient care and research to education. Truly, no one path looks the same and there is no better example than Dr. Lindsey Moseley who found her passion for teaching and education whilst pursuing her Pharm.D. degree. Facing An Identity Crisis Dr. Lindsey Moseley is the Curricular Coordinator and a faculty member at Auburn University Harrison College of Pharmacy.

article thumbnail

Opinion: The emergency room is where the United States’ social problems come home to roost

STAT

From “ Legacy ” by Uché Blackstock, M.D., published by Viking, an imprint of Penguin Publishing Group, a division of Penguin Random House, LLC. Copyright © 2024 by Uché Blackstock, M.D. In the U.S., access to health care has long depended on insurance and a person’s ability to pay, with patients of color making up a disproportionate number of the under- or uninsured, as I have seen firsthand.

Insurance 145
article thumbnail

‘Medicine is going personalised’: Moderna’s UK boss on the coming vaccine revolution

The Guardian - Pharmaceutical Industry

Darius Hughes was a key figure in Pfizer’s pioneering Covid vaccine drive. Now he has changed companies – and sees a big future for mRNA technology The man who launched Pfizer’s Covid-19 vaccine in the UK three years ago – when 90-year-old Margaret Keenan in Coventry became the first person in the world to receive one – is now overseeing the construction of a manufacturing and research centre in Oxfordshire for rival US jab maker Moderna.

Vaccines 144
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

FDA Approves BrainSee, First-in-Class Test to Predict Progression of Alzheimer Disease

Pharmacy Times

BrainSee creates a new standard for progression prediction in Alzheimer disease, marking a step forward in brain health management with non-invasive screening.

FDA 178
article thumbnail

Bipartisan Lawmakers Signal Support for H.R. 1770

Drug Topics

The Equitable Community Access to Pharmacist Services Act seeks to ensure that seniors in rural and underserved communities have access to care and services from pharmacists for common infectious diseases.

560
560
article thumbnail

Pharma takes a gut check of microbiome drugs

PharmaVoice

On the heels of two FDA approvals for microbiome-based therapies, interest in the space is gaining steam.

FDA 279
article thumbnail

UnitedHealth Group kicks off payer earnings, reports $5.5B in Q4 profit

Fierce Healthcare

Industry giant UnitedHealth Group kicked off fourth-quarter earnings for major payers on Friday morning, where it reported $5.5 billion in profit. | Industry giant UnitedHealth Group kicked off fourth-quarter earnings for major payers on Friday morning, where it reported $5.5 billion in profit.

143
143
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

STAT+: Can Wegovy treat depression as well as obesity? New research looks to GLP-1 drugs for mental illnesses

STAT

Drugs like Ozempic and Wegovy — already game changers for diabetes and obesity — are being studied to treat an entirely different growing health problem: mental health illnesses, including depression and bipolar disorder. Early data and anecdotes suggest that this class of GLP-1 drugs could help patients feel less depressed and anxious.

145
145
article thumbnail

JPM: Four ways FDA is seeking to buoy gene therapy

pharmaphorum

Dr Peter Marks, director of the FDA Center for Biologics Evaluation and Research told a packed house in San Francisco for JPM that FDA wants to support gene therapies in 2024.

FDA 138
article thumbnail

Statins Could Potentially Slow Deterioration of Cognitive Function for Those With Alzheimer Disease

Pharmacy Times

Due to the observational nature of the study, the study authors said they cannot determine causal relationships between statins and cognitive decline for patients with Alzheimer disease.

177
177
article thumbnail

Pharmacist Interventions May Improve Clinical Outcomes of Patients With T2D

Drug Topics

By getting involved in patient care, pharmacists can help alleviate the burdens associated with the self-management of type 2 diabetes (T2D).

article thumbnail

Immunotherapy changed the cancer treatment landscape. Is the gut microbiome the next frontier?

PharmaVoice

The president of L.A.’s City of Hope Cancer Center believes the current state of cancer treatments can be greatly improved with a peek into the gut’s many mysteries.

264
264
article thumbnail

JPM24: Amazon rolls out service to connect customers with digital health benefits, taps Omada Health as launch partner

Fierce Healthcare

SAN FRANCISCO—Amazon plans to collaborate with digital health companies to connect customers with virtual care benefits for managing conditions like diabetes and hypertension. | Amazon plans to collaborate with digital health companies to connect customers with virtual care benefits for managing conditions like diabetes and hypertension. The online retail giant tapped virtual-first chronic care provider Omada Health as its first partner.

141
141
article thumbnail

Scientists document first-ever transmitted Alzheimer’s cases, tied to no-longer-used medical procedure

STAT

LONDON — There was something odd about these Alzheimer’s cases. Part of it was the patients’ presentations: Some didn’t have the classic symptoms of the condition. But it was also that the patients were in their 40s and 50s, even their 30s, far younger than people who normally develop the disease. They didn’t even have the known genetic mutations that can set people on the course for such early-onset Alzheimer’s.

article thumbnail

‘The worst I’ve known it’: the struggle to get vital medicines in the UK

The Guardian - Pharmaceutical Industry

Four people with conditions that require consistent medication explain how the shortages have affected their wellbeing NHS medicines shortage putting people at risk, pharmacists warn Analysis: why is UK being hit by medicine supply shortages? More people in the UK are struggling to access vital medicines than ever before, exacerbating conditions from epilepsy to the menopause.

137
137
article thumbnail

Poor Sleep Quality in Early Adulthood Linked With Worse Cognitive Performance in Middle Age

Pharmacy Times

The risk of poor cognitive performance was nearly double in participants who had the greatest number of sleep disturbances compared to the least.

177
177
article thumbnail

Work Pressure During COVID-19 Pandemic Increased Problematic Substance Use Among First Responders

Drug Topics

Problematic substance use was highest among firefighters, followed by emergency medical technicians, and police officers.

551
551
article thumbnail

Alzheimer’s research is hot, but successful patient recruitment will determine its future

PharmaVoice

Key strategies for bringing more patients into the clinical trial fold.

264
264
article thumbnail

Humana's stock tumbles pre-market as it posts $541M loss in Q4

Fierce Healthcare

Humana primed the pump last week for a disappointing fourth quarter call, and its stock again dropped Thursday morning as the company posted a $541 million loss. | Humana primed the pump last week for a disappointing fourth quarter call, and its stock again dropped Thursday morning as the company posted a $541 million loss.

138
138
article thumbnail

Opinion: I’m an anesthesiologist. Kenneth Smith’s execution by nitrogen gas was far from ‘textbook’

STAT

On Thursday evening, the state of Alabama executed Kenneth Eugene Smith by nitrogen gas. Now, there are dueling narratives about what happened. Alabama claims it went perfectly, proving that nitrogen is a humane, effective alternative to lethal injection (which it previously tried, unsuccessfully, to use on Smith). It says that based on this experience, other states should follow its example.

145
145
article thumbnail

Will weight loss drugs kill the fast food business?

The Guardian - Pharmaceutical Industry

Many firms see the dire forecasts as ‘overblown’ but they know they will have to adapt products to make ‘every bite must count’ On a drizzly morning Luton’s takeaways are preparing for the lunchtime rush. McDonald’s is busy with shoppers, while chains from Subway to German Doner Kebab are opening their doors for the approaching army of hungry stomachs.

Hospitals 135
article thumbnail

Deep Brain Stimulation May Benefit Patients With Alzheimer Disease, But More Research Is Needed

Pharmacy Times

Patients who receive stimulation at different parts of the brain may reap benefits.

177
177